BioCentury
ARTICLE | Financial News

Ocular raises $23.8M in series D extension

January 29, 2013 1:28 AM UTC

Ocular Therapeutix Inc. (Bedford, Mass.) raised $23.8 million in an extension of a series D round, bringing the total raised in the round to $37.8 million. All of the company's existing institutional investors participated, including Polaris Venture Partners; Versant Ventures; SV Life Sciences; Sparta LLC; and Ascension Health Ventures. ...